AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24239210 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential treatment
Number of subjects: 282
Study 24239210 — intervention group
Group type: COMPARATOR
Intervention: Concurrent treatment
Number of subjects: 282
Study 21068353 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (200,000 IU retinyl palmitate plus 15 mg Zn/d for 8 weeks)
Number of subjects: 154
Study 21068353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 21068353 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation
Number of subjects: 154
Study 18475165 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg
Number of subjects: 208
Study 18475165 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 208
Study 18475165 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg
Number of subjects: 208
Study 18475165 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 208
Study 16472039 — intervention group
Group type: EXPERIMENTAL
Intervention: CHANGE intervention (supplemental to usual care)
Number of subjects: 250
Study 16472039 — intervention group
Group type: COMPARATOR
Intervention: Usual-care-only group
Number of subjects: 250
Study 14662280 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 5000
Study 14662280 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 5000
Study 14662280 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 5000
Study 14662280 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 5000
Study 14662280 — intervention group
Group type: EXPERIMENTAL
Intervention: Air
Number of subjects: 5000
Study 14662280 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 5000
Study 14662280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antiemetic interventions)
Number of subjects: 5000
Study 11195960 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 106
Study 11195960 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol-medroxyprogesterone
Number of subjects: 106
Study 9068458 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncovered Wallstent
Number of subjects: 82
Study 9068458 — intervention group
Group type: COMPARATOR
Intervention: Knitted nitinol stent
Number of subjects: 82
Study 7983954 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg
Number of subjects: 88
Study 7983954 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 2690739 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm formula
Number of subjects: 502
Study 2690739 — intervention group
Group type: COMPARATOR
Intervention: Donor breast milk
Number of subjects: 502
Study 2690739 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's expressed milk with banked milk supplement
Number of subjects: 502
Study 2690739 — intervention group
Group type: COMPARATOR
Intervention: Donor breast milk in infants with fetal growth retardation
Number of subjects: 502
Study 1131298 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshly extracted juice of 50 g of garlic
Number of subjects: 10
Study 1131298 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshly extracted juice of 50 g of onion
Number of subjects: 10
Study 1131298 — intervention group
Group type: EXPERIMENTAL
Intervention: Ether-extracted essential oils of garlic
Number of subjects: 10
Study 1131298 — intervention group
Group type: EXPERIMENTAL
Intervention: Ether-extracted essential oils of onion
Number of subjects: 10
Study 30985450 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital nighttime intensivist staffing
Number of subjects: 33
Study 30985450 — intervention group
Group type: COMPARATOR
Intervention: Standard daytime intensivist model
Number of subjects: 33
Study 27586512 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and analgesics for 72 hours after abdominal operations
Number of subjects: 113
Study 27586512 — intervention group
Group type: COMPARATOR
Intervention: Only analgesics
Number of subjects: 113
Study 26884660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal/iliohypogastric nerve block (IINB)
Number of subjects: 90
Study 26884660 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Schulte-Steinberg IINB
Number of subjects: 90
Study 26884660 — intervention group
Group type: COMPARATOR
Intervention: Intravenous anesthesia (ketamine-propofol) only (Control)
Number of subjects: 90
Study 23406536 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflazacort (1 mg/kg/day in month one, 1 mg/kg every 2nd day during months two to six)
Number of subjects: 25
Study 23406536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 23406536 — intervention group
Group type: COMPARATOR
Intervention: Natural course (no intervention)
Number of subjects: 25
Study 21931864 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal pea protein administration (250 mg/kg bodyweight in 0.4 ml/kg bodyweight of water)
Number of subjects: 20
Study 21931864 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal pea protein administration
Number of subjects: 20
Study 21931864 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.4 ml/kg bodyweight of water)
Number of subjects: 20
Study 21931864 — intervention group
Group type: COMPARATOR
Intervention: Oral pea protein administration
Number of subjects: 20
Study 20029895 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern-mixture zero-inflated model with compound Poisson random effects
Number of subjects: 0
Study 20029895 — intervention group
Group type: EXPERIMENTAL
Intervention: Quasi-likelihood approach
Number of subjects: 0
Study 17727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-type questions
Number of subjects: 89
Study 17727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective-type questions
Number of subjects: 89
Study 17727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched learners
Number of subjects: 89
Study 17727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mismatched learners
Number of subjects: 89
Study 17727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Construct table format
Number of subjects: 89
Study 17727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Table provided format
Number of subjects: 89
Study 17727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Course ratings
Number of subjects: 89
Study 15272628 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cytoflavin dropper injections once daily for 10 days
Number of subjects: 60
Study 15272628 — intervention group
Group type: COMPARATOR
Intervention: 5% glucose solution (placebo)
Number of subjects: 60
Study 15272628 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cytoflavin
Number of subjects: 60
Study 11232022 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal administration of 100 microgram/day estradiol (E(2)) for 2 days
Number of subjects: 11
Study 11232022 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P) for 2 days
Number of subjects: 11
Study 8829399 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological debriefing at two weeks
Number of subjects: 0
Study 8829399 — intervention group
Group type: COMPARATOR
Intervention: Control (no psychological debriefing)
Number of subjects: 0
Study 1425532 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (individual counselling)
Number of subjects: 48
Study 1425532 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (group therapy)
Number of subjects: 48
Study 1425532 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (school health care setting)
Number of subjects: 48
Study 1425532 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful weight losers
Number of subjects: 48
Study 1425532 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of success
Number of subjects: 48
Study 4011126 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium dobesilate (500 mg, 3 times daily for 3 months)
Number of subjects: 37
Study 4011126 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 capsules daily for 3 months)
Number of subjects: 37
Study 31411793 — intervention group
Group type: COMPARATOR
Intervention: Concomitant therapy (amoxicillin 1 g, clarithromycin 500 mg, metronidazole 500 mg, and lansoprazole 30 mg twice/day for 14 days)
Number of subjects: 397
Study 31411793 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored therapy (amoxicillin 1 g, clarithromycin 500 mg, and lansoprazole 30 mg twice/day for 14 days in point mutation-negative subjects; amoxicillin 1 g, metronidazole 500 mg, and lansoprazole 30 mg twice/day for 14 days in point mutation-positive subjects)
Number of subjects: 397
Study 29866199 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription hydration plan (PHP)
Number of subjects: 15
Study 29866199 — intervention group
Group type: COMPARATOR
Intervention: Normal ad libitum hydration habits (NHP)
Number of subjects: 15
Study 26498173 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent vouchers
Number of subjects: 338
Study 26498173 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent vouchers
Number of subjects: 338
Study 24803153 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 40
Study 24803153 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 40
Study 22595362 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 2000 mg/day
Number of subjects: 409
Study 22595362 — intervention group
Group type: COMPARATOR
Intervention: Lamotrigine (LTG) 200 mg/day
Number of subjects: 409
Study 22595362 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 409
Study 22595362 — intervention group
Group type: COMPARATOR
Intervention: Lamotrigine (LTG)
Number of subjects: 409
Study 19398690 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic health record enhancement (smoking status icons, tobacco treatment reminders, Tobacco Smart Form)
Number of subjects: 132630
Study 19398690 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic health record enhancement
Number of subjects: 132630
Study 19398690 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 132630
Study 17400393 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDCT)
Number of subjects: 2728
Study 16312917 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus medicine
Number of subjects: 75
Study 16312917 — intervention group
Group type: COMPARATOR
Intervention: Medicine
Number of subjects: 75
Study 11786563 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 5'‐triphosphate (ATP) infusion (10 intravenous, 30‐hour infusions every 2 to 4 weeks)
Number of subjects: 58
Study 11786563 — intervention group
Group type: COMPARATOR
Intervention: Control (no ATP)
Number of subjects: 58
Study 9667340 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 20
Study 9667340 — intervention group
Group type: COMPARATOR
Intervention: Tracheal Tube (TT)
Number of subjects: 20
Study 7662755 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional evaluation upon admittance and after 7 days, measuring albumin and body weight/ideal weight ratio.
Number of subjects: 301
Study 7662755 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional evaluation after 7 days for patients who continued hospitalization.
Number of subjects: 301
Study 7662755 — intervention group
Group type: COMPARATOR
Intervention: Comparison of incidence of PEM based on age and type of department.
Number of subjects: 301
Study 2113093 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabbit antithymocyte globulin (polyclonal)
Number of subjects: 82
Study 2113093 — intervention group
Group type: COMPARATOR
Intervention: OKT3 monoclonal antibody
Number of subjects: 82
Study 380615 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 24
Study 380615 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylobarbitone
Number of subjects: 24
Study 380615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31287783 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education and brief action and coping planning intervention (Experimental Group)
Number of subjects: 153
Study 30295931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphaticovenous anastomosis (LVA) surgery
Number of subjects: 27
Study 30295931 — intervention group
Group type: COMPARATOR
Intervention: Compression garment therapy (CGT) after surgery
Number of subjects: 27
Study 26842867 — intervention group
Group type: EXPERIMENTAL
Intervention: Capoeira progressive training program (10 weeks, 1 session per week, 90 minutes each)
Number of subjects: 18
Study 26842867 — intervention group
Group type: EXPERIMENTAL
Intervention: Capoeira progressive training program
Number of subjects: 18
Study 25879419 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 0
Study 25879419 — intervention group
Group type: COMPARATOR
Intervention: Self-help materials on smoking cessation (Control)
Number of subjects: 0
Study 23671894 — intervention group
Group type: EXPERIMENTAL
Intervention: PVA coated nasal packing
Number of subjects: 33
Study 23671894 — intervention group
Group type: COMPARATOR
Intervention: Non-absorbable nasal packing
Number of subjects: 33
Study 21480180 — intervention group
Group type: EXPERIMENTAL
Intervention: Coupled plasma filtration adsorption (CPFA)
Number of subjects: 24
Study 21480180 — intervention group
Group type: COMPARATOR
Intervention: High volume hemofiltration (HVHF)
Number of subjects: 24
Study 21480180 — intervention group
Group type: EXPERIMENTAL
Intervention: CPFA
Number of subjects: 24
Study 21480180 — intervention group
Group type: COMPARATOR
Intervention: HVHF
Number of subjects: 24
Study 19944390 — intervention group
Group type: EXPERIMENTAL
Intervention: Extension tube
Number of subjects: 230
Study 19944390 — intervention group
Group type: COMPARATOR
Intervention: No extension tube (Control)
Number of subjects: 230
Study 17321484 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor (CP) stimulation
Number of subjects: 10
Study 17321484 — intervention group
Group type: COMPARATOR
Intervention: Mock CP trial
Number of subjects: 10
Study 15565568 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprorelin (3.75 mg/mo subcutaneously), flutamide (750 mg/d orally), and tamoxifen (30 mg/d orally)
Number of subjects: 376
Study 15565568 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen alone (30 mg/d orally)
Number of subjects: 376
Study 15565568 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprorelin, flutamide, and tamoxifen
Number of subjects: 376
Study 11327062 — intervention group
Group type: EXPERIMENTAL
Intervention: Root planing and scaling
Number of subjects: 2
Study 11327062 — intervention group
Group type: COMPARATOR
Intervention: Non-scaled sites
Number of subjects: 2
Study 11327062 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaled sites
Number of subjects: 2
Study 9012624 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 20
Study 9012624 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 20
Study 7943588 — intervention group
Group type: EXPERIMENTAL
Intervention: Handsewn anastomosis (Hs)
Number of subjects: 88
Study 7943588 — intervention group
Group type: COMPARATOR
Intervention: Stapled anastomosis (St)
Number of subjects: 88
Study 7943588 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Hs and St
Number of subjects: 88
Study 2905632 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic therapy in schizophrenics with affective heredity
Number of subjects: 0
Study 2905632 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic therapy in schizophrenics with schizophrenic heredity
Number of subjects: 0
Study 31468547 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure, Relaxation, and Rescripting Therapy (ERRT)
Number of subjects: 75
Study 27780669 — intervention group
Group type: EXPERIMENTAL
Intervention: PEACH intervention
Number of subjects: 95
Study 25320361 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg/day
Number of subjects: 0
Study 25320361 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg/day
Number of subjects: 0
Study 25320361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23904684 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 lux light exposure prior to 90 lux light stimulus
Number of subjects: 14
Study 23904684 — intervention group
Group type: COMPARATOR
Intervention: 90 lux light exposure prior to 90 lux light stimulus
Number of subjects: 14
Study 20859562 — intervention group
Group type: EXPERIMENTAL
Intervention: Positioning stents
Number of subjects: 48
Study 20859562 — intervention group
Group type: COMPARATOR
Intervention: Control group (no positioning stents)
Number of subjects: 48
Study 18283233 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime IV 750 mg tid for 10 days
Number of subjects: 142
Study 18283233 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime IV 750 mg tid for 3 days followed by cefuroxime-axetil PO 500 mg bid for 7 days
Number of subjects: 142
Study 18283233 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 142
Study 16172214 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary intake of retinol
Number of subjects: 29133
Study 16172214 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of alpha‐tocopherol
Number of subjects: 29133
Study 16172214 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of gamma‐tocopherol
Number of subjects: 29133
Study 16172214 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intakes of fruits
Number of subjects: 29133
Study 16172214 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intake of vitamin C
Number of subjects: 29133
Study 16172214 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intake of alpha‐tocopherol
Number of subjects: 29133
Study 16172214 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intake of gamma‐tocopherol
Number of subjects: 29133
Study 16172214 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intake of lycopene
Number of subjects: 29133
Study 12853782 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic lithotriptor (DLS)
Number of subjects: 694
Study 12853782 — intervention group
Group type: COMPARATOR
Intervention: Electrohydraulic lithotriptor (MFL)
Number of subjects: 694
Study 12853782 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 694
Study 10378132 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g of azithromycin as a single dose
Number of subjects: 100
Study 10378132 — intervention group
Group type: COMPARATOR
Intervention: 500 mg of azithromycin once daily for 3 days
Number of subjects: 100
Study 8905357 — intervention group
Group type: EXPERIMENTAL
Intervention: High-compliance balloon (HCB)
Number of subjects: 25
Study 8905357 — intervention group
Group type: COMPARATOR
Intervention: Low-compliance balloon (LCB)
Number of subjects: 25
Study 8905357 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HCB and LCB
Number of subjects: 25
Study 2023142 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of carbohydrate in a prepared meal and knowledge provided about its contents
Number of subjects: 56
Study 2023142 — intervention group
Group type: COMPARATOR
Intervention: Laboratory-induced counter-regulatory eating
Number of subjects: 56
Study 6630540 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered cognitive therapy (RET)
Number of subjects: 45
Study 6630540 — intervention group
Group type: COMPARATOR
Intervention: Self-administered attention placebo condition (Logo-therapy)
Number of subjects: 45
Study 6630540 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 45
Study 31277116 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed humidified CO2 insufflation (35°C, 95% relative humidity)
Number of subjects: 63
Study 31277116 — intervention group
Group type: COMPARATOR
Intervention: Standard CO2 insufflation
Number of subjects: 63
Study 28189575 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (duloxetine or fluoxetine)
Number of subjects: 1462
Study 28189575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1462
Study 27165955 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharyngeal electric stimulation (PES)
Number of subjects: 162
Study 27165955 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 162
Study 24933725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cane Cognitive Mediator Scale (CCMS)
Number of subjects: 53
Study 24933725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cane Cognitive Mediator Scale (CCMS) Subjective Norms subscale
Number of subjects: 53
Study 24933725 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial Impact of Assistive Devices Scale (PIADS) Adaptability subscale
Number of subjects: 53
Study 21810729 — intervention group
Group type: COMPARATOR
Intervention: ara-C plus daunorubicin (DNR; 7+3)
Number of subjects: 119
Study 21810729 — intervention group
Group type: EXPERIMENTAL
Intervention: ara-C plus gemtuzumab ozogamicin (7+GO)
Number of subjects: 119
Study 20957842 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency leg movements (HFLM)
Number of subjects: 37
Study 17658025 — intervention group
Group type: EXPERIMENTAL
Intervention: BioEnterics Intragastric Balloon (BIB)
Number of subjects: 22
Study 17658025 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 22
Study 17658025 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BIB and Sham)
Number of subjects: 22
Study 15747805 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based treatment focusing on phonological and morphological structure of Dutch words
Number of subjects: 267
Study 15747805 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based treatment
Number of subjects: 267
Study 12125829 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention program (8 weeks)
Number of subjects: 38
Study 12125829 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38